J. Safra Asset Management’s Gilead Sciences GILD Stock Holding History

J. Safra Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.1K	Buy	309 +137	+80%	+$19.2K	﹤0.01%	266
2025 Q4	$21.1K	Buy	172 +161	+1,464%	+$19.6K	﹤0.01%	322
2025 Q3	$1.22K	Buy	11 +1	+10%	+$114	﹤0.01%	449
2025 Q2	$1.11K	Buy	10 +1	+11%	+$106	﹤0.01%	358
2025 Q1	$1.01K	Buy	9 +5	+125%	+$516	﹤0.01%	334
2024 Q4	$368	Buy	+4	New	+$360	﹤0.01%	331
2016 Q4	–	Sell	-285	Closed	-$23K	–	67
2016 Q3	$23K	Hold	285	–	–	0.04%	132
2016 Q2	$24K	Buy	+285	New	+$25.3K	0.04%	190

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

J. Safra Asset Management's GILD Position: Q1 2026 in Review

J. Safra Asset Management increased its Gilead Sciences (GILD) stake by 80% in Q1 2026, buying an estimated $19.2K and bringing the position to 309 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #266.

J. Safra Asset Management first reported a position in GILD in Q2 2016 and has held it in 8 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

J. Safra Asset Management held 309 shares of Gilead Sciences worth $43.1K as of Q1 2026.
J. Safra Asset Management bought 137 Gilead Sciences shares in Q1 2026, an estimated $19.2K.
Gilead Sciences made up ﹤0.01% of J. Safra Asset Management's portfolio in Q1 2026, its #266 holding.
J. Safra Asset Management first reported a position in Gilead Sciences in Q2 2016 and has held it in 8 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.